According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Chronic Heart Failure (CHF) Devices Market

The global Chronic Heart Failure (CHF) Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Chronic Heart Failure (CHF) Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Heart Failure (CHF) Devices.

Report Scope

The Chronic Heart Failure (CHF) Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Heart Failure (CHF) Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Heart Failure (CHF) Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Heart Failure (CHF) Devices Market Report

Report Metric	Details
Report Name	Chronic Heart Failure (CHF) Devices Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type	Implantable Left Ventricular Assist Device (LVAD) Biventricular Pacemaker Implantable Cardioverter-defibrillators (ICDs) Continuous Positive Air Pressure Device (CPAP) Bi-level Positive Air Pressure Device (BiPAP) Heart Pumps
Segment by Application	Hospital Clinic Household Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Medtronic, Abbott, Johnson & Johnson, Stanley Pharmaceuticals, New Haven Pharmaceuticals, Inc., Boston Scientific Corporation, HeartWare, Biovail Corporation, Abiomed, Symplmed Pharmaceuticals, Berlin Heart GmbH, ReliantHeart, Inc., Cardiokinetix, Biotronik, Jarvik Heart
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Chronic Heart Failure (CHF) Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Chronic Heart Failure (CHF) Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Heart Failure (CHF) Devices Market report?

Ans: The main players in the Chronic Heart Failure (CHF) Devices Market are Medtronic, Abbott, Johnson & Johnson, Stanley Pharmaceuticals, New Haven Pharmaceuticals, Inc., Boston Scientific Corporation, HeartWare, Biovail Corporation, Abiomed, Symplmed Pharmaceuticals, Berlin Heart GmbH, ReliantHeart, Inc., Cardiokinetix, Biotronik, Jarvik Heart

What are the Application segmentation covered in the Chronic Heart Failure (CHF) Devices Market report?

Ans: The Applications covered in the Chronic Heart Failure (CHF) Devices Market report are Hospital, Clinic, Household, Others

What are the Type segmentation covered in the Chronic Heart Failure (CHF) Devices Market report?

Ans: The Types covered in the Chronic Heart Failure (CHF) Devices Market report are Implantable Left Ventricular Assist Device (LVAD), Biventricular Pacemaker, Implantable Cardioverter-defibrillators (ICDs), Continuous Positive Air Pressure Device (CPAP), Bi-level Positive Air Pressure Device (BiPAP), Heart Pumps

1 Chronic Heart Failure (CHF) Devices Market Overview

1.1 Product Overview and Scope of Chronic Heart Failure (CHF) Devices

1.2 Chronic Heart Failure (CHF) Devices Segment by Type

1.2.1 Global Chronic Heart Failure (CHF) Devices Market Value Comparison by Type (2024-2030)

1.2.2 Implantable Left Ventricular Assist Device (LVAD)

1.2.3 Biventricular Pacemaker

1.2.4 Implantable Cardioverter-defibrillators (ICDs)

1.2.5 Continuous Positive Air Pressure Device (CPAP)

1.2.6 Bi-level Positive Air Pressure Device (BiPAP)

1.2.7 Heart Pumps

1.3 Chronic Heart Failure (CHF) Devices Segment by Application

1.3.1 Global Chronic Heart Failure (CHF) Devices Market Value by Application: (2024-2030)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Household

1.3.5 Others

1.4 Global Chronic Heart Failure (CHF) Devices Market Size Estimates and Forecasts

1.4.1 Global Chronic Heart Failure (CHF) Devices Revenue 2019-2030

1.4.2 Global Chronic Heart Failure (CHF) Devices Sales 2019-2030

1.4.3 Global Chronic Heart Failure (CHF) Devices Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Chronic Heart Failure (CHF) Devices Market Competition by Manufacturers

2.1 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Manufacturers (2019-2024)

2.2 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Chronic Heart Failure (CHF) Devices Average Price by Manufacturers (2019-2024)

2.4 Global Chronic Heart Failure (CHF) Devices Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Chronic Heart Failure (CHF) Devices, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Chronic Heart Failure (CHF) Devices, Product Type & Application

2.7 Chronic Heart Failure (CHF) Devices Market Competitive Situation and Trends

2.7.1 Chronic Heart Failure (CHF) Devices Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Chronic Heart Failure (CHF) Devices Players Market Share by Revenue

2.7.3 Global Chronic Heart Failure (CHF) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Chronic Heart Failure (CHF) Devices Retrospective Market Scenario by Region

3.1 Global Chronic Heart Failure (CHF) Devices Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Chronic Heart Failure (CHF) Devices Global Chronic Heart Failure (CHF) Devices Sales by Region: 2019-2030

3.2.1 Global Chronic Heart Failure (CHF) Devices Sales by Region: 2019-2024

3.2.2 Global Chronic Heart Failure (CHF) Devices Sales by Region: 2025-2030

3.3 Global Chronic Heart Failure (CHF) Devices Global Chronic Heart Failure (CHF) Devices Revenue by Region: 2019-2030

3.3.1 Global Chronic Heart Failure (CHF) Devices Revenue by Region: 2019-2024

3.3.2 Global Chronic Heart Failure (CHF) Devices Revenue by Region: 2025-2030

3.4 North America Chronic Heart Failure (CHF) Devices Market Facts & Figures by Country

3.4.1 North America Chronic Heart Failure (CHF) Devices Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Chronic Heart Failure (CHF) Devices Sales by Country (2019-2030)

3.4.3 North America Chronic Heart Failure (CHF) Devices Revenue by Country (2019-2030)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Chronic Heart Failure (CHF) Devices Market Facts & Figures by Country

3.5.1 Europe Chronic Heart Failure (CHF) Devices Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Chronic Heart Failure (CHF) Devices Sales by Country (2019-2030)

3.5.3 Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Chronic Heart Failure (CHF) Devices Market Facts & Figures by Country

3.6.1 Asia Pacific Chronic Heart Failure (CHF) Devices Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Country (2019-2030)

3.6.3 Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Chronic Heart Failure (CHF) Devices Market Facts & Figures by Country

3.7.1 Latin America Chronic Heart Failure (CHF) Devices Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Chronic Heart Failure (CHF) Devices Sales by Country (2019-2030)

3.7.3 Latin America Chronic Heart Failure (CHF) Devices Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Chronic Heart Failure (CHF) Devices Market Facts & Figures by Country

3.8.1 Middle East and Africa Chronic Heart Failure (CHF) Devices Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Chronic Heart Failure (CHF) Devices Sales by Country (2019-2030)

3.8.3 Middle East and Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Chronic Heart Failure (CHF) Devices Sales by Type (2019-2030)

4.1.1 Global Chronic Heart Failure (CHF) Devices Sales by Type (2019-2024)

4.1.2 Global Chronic Heart Failure (CHF) Devices Sales by Type (2025-2030)

4.1.3 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2019-2030)

4.2 Global Chronic Heart Failure (CHF) Devices Revenue by Type (2019-2030)

4.2.1 Global Chronic Heart Failure (CHF) Devices Revenue by Type (2019-2024)

4.2.2 Global Chronic Heart Failure (CHF) Devices Revenue by Type (2025-2030)

4.2.3 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2019-2030)

4.3 Global Chronic Heart Failure (CHF) Devices Price by Type (2019-2030)

5 Segment by Application

5.1 Global Chronic Heart Failure (CHF) Devices Sales by Application (2019-2030)

5.1.1 Global Chronic Heart Failure (CHF) Devices Sales by Application (2019-2024)

5.1.2 Global Chronic Heart Failure (CHF) Devices Sales by Application (2025-2030)

5.1.3 Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2019-2030)

5.2 Global Chronic Heart Failure (CHF) Devices Revenue by Application (2019-2030)

5.2.1 Global Chronic Heart Failure (CHF) Devices Revenue by Application (2019-2024)

5.2.2 Global Chronic Heart Failure (CHF) Devices Revenue by Application (2025-2030)

5.2.3 Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2019-2030)

5.3 Global Chronic Heart Failure (CHF) Devices Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Medtronic

6.1.1 Medtronic Corporation Information

6.1.2 Medtronic Description and Business Overview

6.1.3 Medtronic Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Medtronic Chronic Heart Failure (CHF) Devices Product Portfolio

6.1.5 Medtronic Recent Developments/Updates

6.2 Abbott

6.2.1 Abbott Corporation Information

6.2.2 Abbott Description and Business Overview

6.2.3 Abbott Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Abbott Chronic Heart Failure (CHF) Devices Product Portfolio

6.2.5 Abbott Recent Developments/Updates

6.3 Johnson & Johnson

6.3.1 Johnson & Johnson Corporation Information

6.3.2 Johnson & Johnson Description and Business Overview

6.3.3 Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Johnson & Johnson Chronic Heart Failure (CHF) Devices Product Portfolio

6.3.5 Johnson & Johnson Recent Developments/Updates

6.4 Stanley Pharmaceuticals

6.4.1 Stanley Pharmaceuticals Corporation Information

6.4.2 Stanley Pharmaceuticals Description and Business Overview

6.4.3 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolio

6.4.5 Stanley Pharmaceuticals Recent Developments/Updates

6.5 New Haven Pharmaceuticals, Inc.

6.5.1 New Haven Pharmaceuticals, Inc. Corporation Information

6.5.2 New Haven Pharmaceuticals, Inc. Description and Business Overview

6.5.3 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.5.4 New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product Portfolio

6.5.5 New Haven Pharmaceuticals, Inc. Recent Developments/Updates

6.6 Boston Scientific Corporation

6.6.1 Boston Scientific Corporation Corporation Information

6.6.2 Boston Scientific Corporation Description and Business Overview

6.6.3 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product Portfolio

6.6.5 Boston Scientific Corporation Recent Developments/Updates

6.7 HeartWare

6.6.1 HeartWare Corporation Information

6.6.2 HeartWare Description and Business Overview

6.6.3 HeartWare Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.4.4 HeartWare Chronic Heart Failure (CHF) Devices Product Portfolio

6.7.5 HeartWare Recent Developments/Updates

6.8 Biovail Corporation

6.8.1 Biovail Corporation Corporation Information

6.8.2 Biovail Corporation Description and Business Overview

6.8.3 Biovail Corporation Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Biovail Corporation Chronic Heart Failure (CHF) Devices Product Portfolio

6.8.5 Biovail Corporation Recent Developments/Updates

6.9 Abiomed

6.9.1 Abiomed Corporation Information

6.9.2 Abiomed Description and Business Overview

6.9.3 Abiomed Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Abiomed Chronic Heart Failure (CHF) Devices Product Portfolio

6.9.5 Abiomed Recent Developments/Updates

6.10 Symplmed Pharmaceuticals

6.10.1 Symplmed Pharmaceuticals Corporation Information

6.10.2 Symplmed Pharmaceuticals Description and Business Overview

6.10.3 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product Portfolio

6.10.5 Symplmed Pharmaceuticals Recent Developments/Updates

6.11 Berlin Heart GmbH

6.11.1 Berlin Heart GmbH Corporation Information

6.11.2 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Description and Business Overview

6.11.3 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product Portfolio

6.11.5 Berlin Heart GmbH Recent Developments/Updates

6.12 ReliantHeart, Inc.

6.12.1 ReliantHeart, Inc. Corporation Information

6.12.2 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Description and Business Overview

6.12.3 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.12.4 ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product Portfolio

6.12.5 ReliantHeart, Inc. Recent Developments/Updates

6.13 Cardiokinetix

6.13.1 Cardiokinetix Corporation Information

6.13.2 Cardiokinetix Chronic Heart Failure (CHF) Devices Description and Business Overview

6.13.3 Cardiokinetix Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Cardiokinetix Chronic Heart Failure (CHF) Devices Product Portfolio

6.13.5 Cardiokinetix Recent Developments/Updates

6.14 Biotronik

6.14.1 Biotronik Corporation Information

6.14.2 Biotronik Chronic Heart Failure (CHF) Devices Description and Business Overview

6.14.3 Biotronik Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Biotronik Chronic Heart Failure (CHF) Devices Product Portfolio

6.14.5 Biotronik Recent Developments/Updates

6.15 Jarvik Heart

6.15.1 Jarvik Heart Corporation Information

6.15.2 Jarvik Heart Chronic Heart Failure (CHF) Devices Description and Business Overview

6.15.3 Jarvik Heart Chronic Heart Failure (CHF) Devices Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Jarvik Heart Chronic Heart Failure (CHF) Devices Product Portfolio

6.15.5 Jarvik Heart Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Chronic Heart Failure (CHF) Devices Industry Chain Analysis

7.2 Chronic Heart Failure (CHF) Devices Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Chronic Heart Failure (CHF) Devices Production Mode & Process

7.4 Chronic Heart Failure (CHF) Devices Sales and Marketing

7.4.1 Chronic Heart Failure (CHF) Devices Sales Channels

7.4.2 Chronic Heart Failure (CHF) Devices Distributors

7.5 Chronic Heart Failure (CHF) Devices Customers

8 Chronic Heart Failure (CHF) Devices Market Dynamics

8.1 Chronic Heart Failure (CHF) Devices Industry Trends

8.2 Chronic Heart Failure (CHF) Devices Market Drivers

8.3 Chronic Heart Failure (CHF) Devices Market Challenges

8.4 Chronic Heart Failure (CHF) Devices Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Medtronic Inc

Abbott

Johnson & Johnson

Stanley Pharmaceuticals

New Haven Pharmaceuticals, Inc.

Boston Scientific Corporation

HeartWare

Biovail Corporation

Abiomed Inc

Symplmed Pharmaceuticals

List of Tables

Table 1. Global Chronic Heart Failure (CHF) Devices Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Chronic Heart Failure (CHF) Devices Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Chronic Heart Failure (CHF) Devices Market Competitive Situation by Manufacturers in 2023

Table 4. Global Chronic Heart Failure (CHF) Devices Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Chronic Heart Failure (CHF) Devices Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Chronic Heart Failure (CHF) Devices Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Chronic Heart Failure (CHF) Devices Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Chronic Heart Failure (CHF) Devices, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Chronic Heart Failure (CHF) Devices, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Chronic Heart Failure (CHF) Devices, Product Type & Application

Table 12. Global Key Manufacturers of Chronic Heart Failure (CHF) Devices, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Chronic Heart Failure (CHF) Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Heart Failure (CHF) Devices as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Chronic Heart Failure (CHF) Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Chronic Heart Failure (CHF) Devices Sales by Region (2019-2024) & (K Units)

Table 18. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2019-2024)

Table 19. Global Chronic Heart Failure (CHF) Devices Sales by Region (2025-2030) & (K Units)

Table 20. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2025-2030)

Table 21. Global Chronic Heart Failure (CHF) Devices Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Region (2019-2024)

Table 23. Global Chronic Heart Failure (CHF) Devices Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Region (2025-2030)

Table 25. North America Chronic Heart Failure (CHF) Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Chronic Heart Failure (CHF) Devices Sales by Country (2019-2024) & (K Units)

Table 27. North America Chronic Heart Failure (CHF) Devices Sales by Country (2025-2030) & (K Units)

Table 28. North America Chronic Heart Failure (CHF) Devices Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Chronic Heart Failure (CHF) Devices Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Chronic Heart Failure (CHF) Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Chronic Heart Failure (CHF) Devices Sales by Country (2019-2024) & (K Units)

Table 32. Europe Chronic Heart Failure (CHF) Devices Sales by Country (2025-2030) & (K Units)

Table 33. Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Chronic Heart Failure (CHF) Devices Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Chronic Heart Failure (CHF) Devices Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Chronic Heart Failure (CHF) Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Chronic Heart Failure (CHF) Devices Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Chronic Heart Failure (CHF) Devices Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Chronic Heart Failure (CHF) Devices Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Chronic Heart Failure (CHF) Devices Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Chronic Heart Failure (CHF) Devices Sales (K Units) by Type (2019-2024)

Table 51. Global Chronic Heart Failure (CHF) Devices Sales (K Units) by Type (2025-2030)

Table 52. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2019-2024)

Table 53. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Type (2025-2030)

Table 54. Global Chronic Heart Failure (CHF) Devices Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Chronic Heart Failure (CHF) Devices Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2019-2024)

Table 57. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Type (2025-2030)

Table 58. Global Chronic Heart Failure (CHF) Devices Price (US$/Unit) by Type (2019-2024)

Table 59. Global Chronic Heart Failure (CHF) Devices Price (US$/Unit) by Type (2025-2030)

Table 60. Global Chronic Heart Failure (CHF) Devices Sales (K Units) by Application (2019-2024)

Table 61. Global Chronic Heart Failure (CHF) Devices Sales (K Units) by Application (2025-2030)

Table 62. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2019-2024)

Table 63. Global Chronic Heart Failure (CHF) Devices Sales Market Share by Application (2025-2030)

Table 64. Global Chronic Heart Failure (CHF) Devices Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Chronic Heart Failure (CHF) Devices Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2019-2024)

Table 67. Global Chronic Heart Failure (CHF) Devices Revenue Market Share by Application (2025-2030)

Table 68. Global Chronic Heart Failure (CHF) Devices Price (US$/Unit) by Application (2019-2024)

Table 69. Global Chronic Heart Failure (CHF) Devices Price (US$/Unit) by Application (2025-2030)

Table 70. Medtronic Corporation Information

Table 71. Medtronic Description and Business Overview

Table 72. Medtronic Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Medtronic Chronic Heart Failure (CHF) Devices Product

Table 74. Medtronic Recent Developments/Updates

Table 75. Abbott Corporation Information

Table 76. Abbott Description and Business Overview

Table 77. Abbott Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Abbott Chronic Heart Failure (CHF) Devices Product

Table 79. Abbott Recent Developments/Updates

Table 80. Johnson & Johnson Corporation Information

Table 81. Johnson & Johnson Description and Business Overview

Table 82. Johnson & Johnson Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Johnson & Johnson Chronic Heart Failure (CHF) Devices Product

Table 84. Johnson & Johnson Recent Developments/Updates

Table 85. Stanley Pharmaceuticals Corporation Information

Table 86. Stanley Pharmaceuticals Description and Business Overview

Table 87. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Stanley Pharmaceuticals Chronic Heart Failure (CHF) Devices Product

Table 89. Stanley Pharmaceuticals Recent Developments/Updates

Table 90. New Haven Pharmaceuticals, Inc. Corporation Information

Table 91. New Haven Pharmaceuticals, Inc. Description and Business Overview

Table 92. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. New Haven Pharmaceuticals, Inc. Chronic Heart Failure (CHF) Devices Product

Table 94. New Haven Pharmaceuticals, Inc. Recent Developments/Updates

Table 95. Boston Scientific Corporation Corporation Information

Table 96. Boston Scientific Corporation Description and Business Overview

Table 97. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Boston Scientific Corporation Chronic Heart Failure (CHF) Devices Product

Table 99. Boston Scientific Corporation Recent Developments/Updates

Table 100. HeartWare Corporation Information

Table 101. HeartWare Description and Business Overview

Table 102. HeartWare Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. HeartWare Chronic Heart Failure (CHF) Devices Product

Table 104. HeartWare Recent Developments/Updates

Table 105. Biovail Corporation Corporation Information

Table 106. Biovail Corporation Description and Business Overview

Table 107. Biovail Corporation Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Biovail Corporation Chronic Heart Failure (CHF) Devices Product

Table 109. Biovail Corporation Recent Developments/Updates

Table 110. Abiomed Corporation Information

Table 111. Abiomed Description and Business Overview

Table 112. Abiomed Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Abiomed Chronic Heart Failure (CHF) Devices Product

Table 114. Abiomed Recent Developments/Updates

Table 115. Symplmed Pharmaceuticals Corporation Information

Table 116. Symplmed Pharmaceuticals Description and Business Overview

Table 117. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Symplmed Pharmaceuticals Chronic Heart Failure (CHF) Devices Product

Table 119. Symplmed Pharmaceuticals Recent Developments/Updates

Table 120. Berlin Heart GmbH Corporation Information

Table 121. Berlin Heart GmbH Description and Business Overview

Table 122. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Berlin Heart GmbH Chronic Heart Failure (CHF) Devices Product

Table 124. Berlin Heart GmbH Recent Developments/Updates

Table 125. ReliantHeart, Inc. Corporation Information

Table 126. ReliantHeart, Inc. Description and Business Overview

Table 127. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. ReliantHeart, Inc. Chronic Heart Failure (CHF) Devices Product

Table 129. ReliantHeart, Inc. Recent Developments/Updates

Table 130. Cardiokinetix Corporation Information

Table 131. Cardiokinetix Description and Business Overview

Table 132. Cardiokinetix Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Cardiokinetix Chronic Heart Failure (CHF) Devices Product

Table 134. Cardiokinetix Recent Developments/Updates

Table 135. Biotronik Corporation Information

Table 136. Biotronik Description and Business Overview

Table 137. Biotronik Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Biotronik Chronic Heart Failure (CHF) Devices Product

Table 139. Biotronik Recent Developments/Updates

Table 140. Jarvik Heart Corporation Information

Table 141. Jarvik Heart Description and Business Overview

Table 142. Jarvik Heart Chronic Heart Failure (CHF) Devices Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Jarvik Heart Chronic Heart Failure (CHF) Devices Product

Table 144. Jarvik Heart Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Chronic Heart Failure (CHF) Devices Distributors List

Table 148. Chronic Heart Failure (CHF) Devices Customers List

Table 149. Chronic Heart Failure (CHF) Devices Market Trends

Table 150. Chronic Heart Failure (CHF) Devices Market Drivers

Table 151. Chronic Heart Failure (CHF) Devices Market Challenges

Table 152. Chronic Heart Failure (CHF) Devices Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Chronic Heart Failure (CHF) Devices

Figure 2. Global Chronic Heart Failure (CHF) Devices Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Chronic Heart Failure (CHF) Devices Market Share by Type in 2023 & 2030

Figure 4. Implantable Left Ventricular Assist Device (LVAD) Product Picture

Figure 5. Biventricular Pacemaker Product Picture

Figure 6. Implantable Cardioverter-defibrillators (ICDs) Product Picture

Figure 7. Continuous Positive Air Pressure Device (CPAP) Product Picture

Figure 8. Bi-level Positive Air Pressure Device (BiPAP) Product Picture

Figure 9. Heart Pumps Product Picture

Figure 10. Global Chronic Heart Failure (CHF) Devices Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 11. Global Chronic Heart Failure (CHF) Devices Market Share by Application in 2023 & 2030

Figure 12. Hospital

Figure 13. Clinic

Figure 14. Household

Figure 15. Others

Figure 16. Global Chronic Heart Failure (CHF) Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Chronic Heart Failure (CHF) Devices Market Size (2019-2030) & (US$ Million)

Figure 18. Global Chronic Heart Failure (CHF) Devices Sales (2019-2030) & (K Units)

Figure 19. Global Chronic Heart Failure (CHF) Devices Average Price (US$/Unit) & (2019-2030)

Figure 20. Chronic Heart Failure (CHF) Devices Report Years Considered

Figure 21. Chronic Heart Failure (CHF) Devices Sales Share by Manufacturers in 2023

Figure 22. Global Chronic Heart Failure (CHF) Devices Revenue Share by Manufacturers in 2023

Figure 23. The Global 5 and 10 Largest Chronic Heart Failure (CHF) Devices Players: Market Share by Revenue in 2023

Figure 24. Chronic Heart Failure (CHF) Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 25. Global Chronic Heart Failure (CHF) Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 26. North America Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2019-2030)

Figure 27. North America Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2019-2030)

Figure 28. U.S. Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Canada Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Europe Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2019-2030)

Figure 31. Europe Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2019-2030)

Figure 32. Germany Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. France Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. U.K. Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Italy Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Russia Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Asia Pacific Chronic Heart Failure (CHF) Devices Sales Market Share by Region (2019-2030)

Figure 38. Asia Pacific Chronic Heart Failure (CHF) Devices Revenue Market Share by Region (2019-2030)

Figure 39. China Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Japan Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. South Korea Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. India Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Australia Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Taiwan Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Indonesia Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Thailand Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Malaysia Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Philippines Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Latin America Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2019-2030)

Figure 50. Latin America Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2019-2030)

Figure 51. Mexico Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Brazil Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Argentina Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Middle East & Africa Chronic Heart Failure (CHF) Devices Sales Market Share by Country (2019-2030)

Figure 55. Middle East & Africa Chronic Heart Failure (CHF) Devices Revenue Market Share by Country (2019-2030)

Figure 56. Turkey Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 57. Saudi Arabia Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 58. UAE Chronic Heart Failure (CHF) Devices Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 59. Global Sales Market Share of Chronic Heart Failure (CHF) Devices by Type (2019-2030)

Figure 60. Global Revenue Market Share of Chronic Heart Failure (CHF) Devices by Type (2019-2030)

Figure 61. Global Chronic Heart Failure (CHF) Devices Price (US$/Unit) by Type (2019-2030)

Figure 62. Global Sales Market Share of Chronic Heart Failure (CHF) Devices by Application (2019-2030)

Figure 63. Global Revenue Market Share of Chronic Heart Failure (CHF) Devices by Application (2019-2030)

Figure 64. Global Chronic Heart Failure (CHF) Devices Price (US$/Unit) by Application (2019-2030)

Figure 65. Chronic Heart Failure (CHF) Devices Value Chain

Figure 66. Chronic Heart Failure (CHF) Devices Production Process

Figure 67. Channels of Distribution (Direct Vs Distribution)

Figure 68. Distributors Profiles

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Myocardial Infarction Test Kit Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-36C13067

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Automated External Defibrillator (AED) Pads Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-8U12890

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Femoral Arterial Cannulae Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-11S7828

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

Global Cardiovascular Disease Test Kit Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-21Z13204

Mon Apr 29 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions